SCOPE HEALTH

FDA Regulatory Profile

SCOPE HEALTH appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0499-2026, Class II) was initiated on April 20, 2026.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-0499-2026Class IIOptase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for ScopApril 20, 2026